Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Rating) has been given a consensus rating of “Hold” by the nine ratings firms that are covering the firm, reports Marketbeat.com. One equity research analyst has rated the stock with a sell recommendation, four
Design Tweaks, Art Warm Up a Williamsburg Townhouse
Got a project to propose for The Insiders? Contact Cara at caramia447 [at] gmail [dot] com
In a sadly not atypical situation of our evolving borough, Keren Richter’s clients had bought what she called a “quintessential old brick townhouse”
